Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma
Nom du journal : Invest New Drugs
Année : 2009
Volume : 7
Page de départ : 482
Page de fin : 489